Cited by 271Liver Disease and TransplantationGastrointestinal motility and disordersGut microbiota and health

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites

Pérez-Paramo, María, Muñoz, Javier, Albillos, Agustín, Freile, Isabel, Portero, Francisca, Santos, Martín, Ortiz-Berrocal, José·2000·Hepatology

DOI 10.1002/hep.510310109

Open this paper in CoChat — free account

Abstract

Bacterial translocation appears to be an important mechanism in the pathogenesis of spontaneous infections in cirrhosis. Cirrhotic patients are commonly treated with β-adrenoceptor blockers, but the impact of this treatment in the factors promoting bacterial translocation has not been investigated. This study was aimed at investigating in cirrhotic rats with ascites the effect of propranolol on intestinal bacterial load, transit, and permeability of the bowel and on the rate of bacterial translocation. Bacterial translocation to mesenteric lymph nodes and intestinal bacterial overgrowth, permeability (urinary excretion of 99m Tc-diethylenetriaminepentaacetic acid [99m Tc-DTPA]), and transit (geometric center ratio of 51 Cr) were assessed in 29 rats with carbon tetrachloride (CCl 4) cirrhosis and 20 controls. These variables were then measured in 12 placebo- and in 13 propranolol-treated ascitic cirrhotic rats. Bacterial translocation was present in 48% of the cirrhotic rats and in none of the controls. Cirrhotic rats with intestinal bacterial overgrowth had a significantly higher rate of translocation and slower intestinal transit than those without it. Among the 15 rats with overgrowth and a 99m Tc-DTPA excretion greater than 10%, 15 had translocation and 2 had bacterial peritonitis. Only 1 of the 14 rats with either intestinal overgrowth or a 99m Tc-DTPA excretion greater than 10% presented translocation. Compared with the placebo group, propranolol-treated animals had significantly lower portal pressure, faster intestinal transit, and lower rates of bacterial overgrowth and translocation. In ascitic cirrhotic rats, bacterial translocation results from intestinal overgrowth and severe damage to gut permeability. In this setting, intestinal overgrowth is associated with intestinal hypomotility. Propranolol accelerates the intestinal transit, decreasing the rates of bacterial overgrowth and translocation.

Integrity signals

Registry

Crossref · 10.1002/hep.510310109

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Intestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
Ginés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Increased Intestinal Permeability Associated With Infection in Burn Patients
Ziegler, T. R. (1988) · Archives of Surgery · doi:10.1001/archsurg.1988.01400350027003 · Cited by 316
Accurate measurement of intestinal transit in the rat
Miller, M. S., Galligan, J. J., & Burks, T. F. (1981) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(81)90110-8 · Cited by 288
High Yield Micronodular Cirrhosis in the Rat
Proctor, E., & Chatamra, K. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80126-1 · Cited by 286
Small Intestine Dysmotility and Bacterial Overgrowth in Cirrhotic Patients With Spontaneous Bacterial Peritonitis
Chang, C., Chen, G., Lien, H., & Yeh, H. (1998) · Hepatology · doi:10.1002/hep.510280504 · Cited by 261
Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites
García–Tsao, G., Lee, F., Barden, G. E., Cartun, R. W., & West, A. B. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90147-7 · Cited by 247
Small bowel bacterial overgrowth in patients with alcoholic cirrhosis
Morencos, F. C., Castano, G. D. L. H., Ramos, L. M., Arias, M. J. L., Ledesma, F., & Romero, F. P. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02282340 · Cited by 246
Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites
Guarner, C., Runyon, B. A., Young, S., Heck, M., & Sheikh, M. Y. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80474-6 · Cited by 237
Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis
Runyon, B. A., Squier, S. U., & Borzio, M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80241-6 · Cited by 218

Show all 25 references

Sorted by citations

Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Self-citation
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Albillos, A., Lario, M., & Álvarez-Mon, M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.010 · Cited by 1,242
Self-citation
Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
Jalan, R., Fernandez, J., Wiest, R., Schnabl, B., Moreau, R., Angeli, P., Stadlbauer, V., Gustot, T., Bernardi, M., Canton, R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.024 · Cited by 906
Self-citation
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826
Guidelines on the management of ascites in cirrhosis
Aithal, G. P., Palaniyappan, N., China, L., Härmälä, S., Macken, L., Ryan, J. M., Wilkes, E. A., Moore, K., Leithead, J. A., Hayes, P. C., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321790 · Cited by 680
Bacterial translocation (BT) in cirrhosis†
Wiest, R., & Garcia‐Tsao, G. (2005) · Hepatology · doi:10.1002/hep.20632 · Cited by 677
The gut microbiome and liver cancer: mechanisms and clinical translation
Yu, L.-X., & Schwabe, R. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.72 · Cited by 634
Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis
Tandon, P., & García–Tsao, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-2008-1040319 · Cited by 549
Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis
García–Tsao, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.22580 · Cited by 466
Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement
Albillos, A., de la Hera, A., González, M., Moya, J. L., Calleja, J. L., Monserrat, J., Ruíz-del-Árbol, L., & Álvarez‐Mon, M. (2003) · Hepatology · doi:10.1053/jhep.2003.50038 · Cited by 449
Self-citation
Targeting the gut-liver axis in liver disease
Wiest, R., Albillos, A., Trauner, M., Bajaj, J. S., & Jalan, R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.007 · Cited by 427
Self-citation
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club
Wong, F. S.-H., Bernardi, M., Balk, R., Christman, B., Moreau, R., Garcia-Tsao, G., Patch, D., Soriano, G., Hoefs, J., & Navasa, M. (2005) · Gut · doi:10.1136/gut.2004.038679 · Cited by 390
Spontaneous bacterial peritonitis: recent guidelines and beyond
Wiest, R., Krag, A. A., & Gerbes, A. (2011) · Gut · doi:10.1136/gutjnl-2011-300779 · Cited by 384
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
Reiberger, T., Ferlitsch, A., Payer, B. A., Mandorfer, M., Heinisch, B. B., Hayden, H., Lammert, F., Trauner, M. A., Peck‐Radosavljevic, M., & Vogelsang, H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.011 · Cited by 328
Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats
Lorenzo-Zúñiga, V., Bartolí, R., Planas, R., Hofmann, A. F., Viñado, B., Hagey, L. R., Hernández, J. M., Mañé, J., Alvarez, M. A., Ausina, V., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50116 · Cited by 321
Infection, coagulation, and variceal bleeding in cirrhosis
Thalheimer, U., Triantos, C. K., Samonakis, D. N., Patch, D., & Burroughs, A. K. (2005) · Gut · doi:10.1136/gut.2004.048181 · Cited by 316
The importance of the gastrointestinal system in the pathogenesis of heart failure
Krack, A., Sharma, R., Figulla, H. R., & Anker, S. D. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi389 · Cited by 280
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
Rahman, M. M., Islam, F., Harun-Or-Rashid, M., Mamun, A. A., Rahaman, M. S., Islam, M. M., Meem, A. F. K., Sutradhar, P. R., Mitra, S., Mimi, A. A., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.903570 · Cited by 272
Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications
Bellot, P., Francés, R., & Such, J. M. (2012) · Liver International · doi:10.1111/liv.12021 · Cited by 255
β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis
Senzolo, M., Cholongitas, E., Burra, P., Leandro, G., Thalheimer, U., Patch, D., & Burroughs, A. K. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02038.x · Cited by 241
Microbiota and the gut-liver axis: Bacterial translocation, inflammation and infection in cirrhosis
Giannelli, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i45.16795 · Cited by 242
Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg
Arab, J. P., Martín‐Mateos, R., & Shah, V. H. (2017) · Hepatology International · doi:10.1007/s12072-017-9798-x · Cited by 233
Liver cirrhosis
Pinzani, M., Rosselli, M., & Zuckermann, M. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.009 · Cited by 228
Pharmacological Reduction of Portal Pressure and Long-Term Risk of First Variceal Bleeding in Patients with Cirrhosis
Turnés, J., García‐Pagán, J. C., Abraldeṣ, J. G., Hernández‐Guerra, M., Dell’Era, A., & Bosch, J. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00453.x · Cited by 225
The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease: Figure 1
Krag, A. A., Wiest, R., Albillos, A., & Gluud, L. L. (2012) · Gut · doi:10.1136/gutjnl-2011-301348 · Cited by 210
Self-citation
Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy
Gupta, A., Dhiman, R. K., Kumari, S., Rana, S., Agarwal, R., Duseja, A., & Chawla, Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.017 · Cited by 202
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Trebicka, J., Bork, P., Krag, A. A., & Arumugam, M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00376-3 · Cited by 204
Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense
Teltschik, Z., Wiest, R., Beisner, J., Nuding, S., Hofmann, C., Schöelmerich, J., Bevins, C. L., Stange, E. F., & Wehkamp, J. (2011) · Hepatology · doi:10.1002/hep.24789 · Cited by 196
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
Fukui, H. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.425 · Cited by 201
C-Reactive protein predicts short-term mortality in patients with cirrhosis
Cervoni, J., Thévenot, T., Weil, D., Muel, E., Barbot, O., Sheppard, F., Monnet, É., & Martino, V. D. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.030 · Cited by 193
Gut microflora in the pathogenesis of the complications of cirrhosis
García–Tsao, G., & Wiest, R. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.10.005 · Cited by 193
Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
Úbeda, M., Lario, M., Muñoz, L., Borrero, M.-J., Rodríguez-Serrano, M., Sánchez-Díaz, A.-M., del Campo, R., Lledó, L., Pastor, Ó., García-Bermejo, L., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.12.010 · Cited by 178
Self-citation
Immune Dysfunction in Cirrhosis
Noor, M. T., & Manoria, P. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2016.00056 · Cited by 176
Bacterial translocation and its consequences in patients with cirrhosis
Guarner, C., & Soriano, G. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200501000-00006 · Cited by 174
Peripheral Blood Mononuclear Cell Expression of Toll–Like Receptors and Relation to Cytokine Levels in Cirrhosis
Riordan, S. M., Skinner, N. A., Nagree, A., McCallum, H., McIver, C. J., Kurtovic, J., Hamilton, J. A., Bengmark, S., Williams, R. L., & Visvanathan, K. (2003) · Hepatology · doi:10.1053/jhep.2003.50180 · Cited by 171
Risk factors and outcome of bacterial infections in cirrhosis
Bruns, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2542 · Cited by 148
Beta adrenergic blockade and decompensated cirrhosis
Reiberger, T., & Mandorfer, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.001 · Cited by 146
Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications
Ponziani, F. R., Zocco, M. A., Cerrito, L., Gasbarrini, A., & Pompili, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1481747 · Cited by 139
Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis
Chiva, M., Soriano, G., Rochat, I., Peralta, C., Rochat, F., Llovet, T., Mirelis, B., Schiffrin, E. J., Guarner, C., & Balanzó, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00142-3 · Cited by 139
Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced Cirrhosis
Lebrec, D., Thabut, D., Oberti, F., Perarnau, J., Condat, B., Barraud, H., Saliba, F., Carbonell, N., Renard, P., Ramond, M.-J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.040 · Cited by 136
The emerging role of the gut in chronic heart failure
Sandek, A., Rauchhaus, M., Anker, S. D., & von Haehling, S. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32830a4c6e · Cited by 134
Microbial Translocation in Chronic Liver Diseases
Pinzone, M. R., Celesia, B. M., Rosa, M. D., Cacopardo, B. S., & Nunnari, G. (2012) · International Journal of Microbiology · doi:10.1155/2012/694629 · Cited by 121
Bacterial infections in cirrhosis: treatment and prophylaxis
García–Tsao, G. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.006 · Cited by 119
The intestinal flora and bacterial infection in cirrhosis
Riordan, S. M., & Williams, R. L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.001 · Cited by 112
Gut-liver axis signaling in portal hypertension
Simbrunner, B., Mandorfer, M., Trauner, M., & Reiberger, T. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i39.5897 · Cited by 113
Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed?
Scarpellini, E., Valenza, V., Gabrielli, M., Lauritano, E. C., Perotti, G., Merra, G., Lago, A. D., Ojetti, V., Ainora, M. E., Santoro, M. C., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.558 · Cited by 110
Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis
Bauer, T., Fernández, J., Navasa, M., Vilà, J., & Rodés, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00003-x · Cited by 110
Sepsis in alcohol-related liver disease
Gustot, T., Fernández, J., Szabó, G., Albillos, A., Louvet, A., Jalan, R., Moreau, R., & Moreno, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.013 · Cited by 108
Self-citation
Meta‐analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices
Thiele, M. S., Krag, A. A., Rohde, U., & Gluud, L. L. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05074.x · Cited by 105
Gut flora and bacterial translocation in chronic liver disease
Almeida, J. A. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i10.1493 · Cited by 105
Gut microbiome and liver disease
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.005 · Cited by 106
Gut Bacterial Translocation Contributes to Microinflammation in Experimental Uremia
Wang, F., Zhang, P., Jiang, H., & Cheng, S. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2242-0 · Cited by 102
The multifactorial mechanisms of bacterial infection in decompensated cirrhosis
der Merwe, V., Chokshi, S., Bernsmeier, C., & Albillos, A. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.029 · Cited by 102
Self-citation
Bloodstream infections in patients with liver cirrhosis
Bartoletti, M., Giannella, M., Lewis, R. E., & Viale, P. (2016) · Virulence · doi:10.1080/21505594.2016.1141162 · Cited by 96
The chronic use of beta‐blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis
Merli, M., Lucidi, C., Gregorio, V. D., Giannelli, V., Giusto, M., Ceccarelli, G., Riggio, O., & Venditti, M. (2014) · Liver International · doi:10.1111/liv.12593 · Cited by 95
A cross-talk between gut microbiome, salt and hypertension
Naqvi, S., Asar, T. O., Kumar, V., Al-Abbasi, F. A., Alhayyani, S., Kamal, M. A., & Anwar, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111156 · Cited by 95
Current management of the complications of portal hypertension: variceal bleeding and ascites
Dib, N. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051700 · Cited by 91
Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats
Chiva, M., Guarner, C., Peralta, C., Llovet, T., Gómez, G. M., Soriano, G., & Balanzó, J. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200302000-00007 · Cited by 89
Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers
Bang, U. C., Benfield, T., Hyldstrup, L., Jensen, J. B., & Bendtsen, F. (2016) · Liver International · doi:10.1111/liv.13119 · Cited by 88
Current Management of the Complications of Cirrhosis and Portal Hypertension: Variceal Hemorrhage, Ascites, and Spontaneous Bacterial Peritonitis
García–Tsao, G. (2016) · Digestive Diseases · doi:10.1159/000444551 · Cited by 85
The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective
Wang, L., Cao, Z.-M., Zhang, L., Li, J.-M., & Lv, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923599 · Cited by 89
Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications
Tsiaoussis, G. I. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i17.2058 · Cited by 83
Spontaneous bacterial peritonitis: a historical perspective
García–Tsao, G. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.001 · Cited by 80
How to Prevent Varices From Bleeding: Shades of Grey—The Case for Nonselective β Blockers
Thalheimer, U., Bosch, J., & Burroughs, A. K. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.028 · Cited by 80
Novel perspectives in the management of decompensated cirrhosis
Bernardi, M., & Caraceni, P. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0045-2 · Cited by 81
Comparison of Two Protocols of Carbon Tetrachloride-Induced Cirrhosis in Rats – Improving Yield and Reproducibility
Fortea, J. I., Fernández-Mena, C., Puerto, M., Ripoll, C., Almagro, J., Bañares, J., Bellón, J. M., Bañares, R., & Vaquero, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-27427-9 · Cited by 79
Non‐selective beta‐blockers may reduce risk of hepatocellular carcinoma: a meta‐analysis of randomized trials
Thiele, M. S., Albillos, A., Abazi, R., Wiest, R., Gluud, L. L., & Krag, A. A. (2015) · Liver International · doi:10.1111/liv.12782 · Cited by 77
Self-citation
Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis
Tergast, T. L., Kimmann, M., Laser, H., Gerbel, S., Manns, M. P., Cornberg, M., & Maasoumy, B. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15439 · Cited by 75
Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis
Tazi, K. A., Barrière, É., Moreau, R., Heller, J., Sogni, P., Pateron, D., Poirel, O., & Lebrec, D. (2002) · Gastroenterology · doi:10.1053/gast.2002.33586 · Cited by 74
Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis
Ghosh, G., & Jesudian, A. B. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.08.006 · Cited by 71
Mesenteric Th1 polarization and monocyte TNF‐α production: First steps to systemic inflammation in rats with cirrhosis†
Muñoz, L., Albillos, A., Nieto, M., Reyes, E., Lledó, L., Monserrat, J., Sanz, E., de la Hera, A., & Alvarez‐Mon, M. (2005) · Hepatology · doi:10.1002/hep.20799 · Cited by 70
Self-citation
Increased tumour necrosis factor production in mesenteric lymph nodes of cirrhotic patients with ascites
Genesca, J. (2003) · Gut · doi:10.1136/gut.52.7.1054 · Cited by 70
Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding
Stanley, A. J., Dickson, S., Hayes, P. C., Forrest, E. H., Mills, P. R., Tripathi, D., Leithead, J., Macbeth, K., Smith, L., Gaya, D. R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.015 · Cited by 70
Beta-1 blocker improves survival of septic rats through preservation of gut barrier function
Mori, K., Morisaki, H., Yajima, S., Suzuki, T., Ishikawa, A., Nakamura, N., Innami, Y., & Takeda, J. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2326-x · Cited by 70
Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites
de Vos, M., Vroey, B. D., Garcia, B. G., Roy, C., Kidd, F., Henrion, J., & Deltenre, P. (2013) · Liver International · doi:10.1111/liv.12210 · Cited by 67
Spontaneous bacterial peritonitis—diagnosis, treatment and prevention
Mowat, C., & Stanley, A. J. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01116.x · Cited by 65
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
(2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2018.1005 · Cited by 65
Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis
Muñoz, L., Borrero, M. J., Cantera, M., Lario, M., Díaz, D., Francés, R., Monserrat, J., Pastor, Ó., Aguado-Fraile, E., Such, J. M., et al. (2012) · Hepatology · doi:10.1002/hep.25854 · Cited by 64
Self-citation
Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis
Worlicek, M., Knebel, K., Linde, H. ‐., Moleda, L., Schölmerich, J., Straub, R. H., & Wiest, R. (2010) · Gut · doi:10.1136/gut.2009.185413 · Cited by 61
Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding
Funakoshi, N., Duny, Y., Valats, J.-C., Ségalas-Largey, F., Flori, N., Bismuth, M., Daurès, J., & Blanc, P. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30934-2 · Cited by 57
Markers of bacterial translocation in end-stage liver disease
Koutsounas, I. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i20.2264 · Cited by 55
Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host
Alaish, S. M., Smith, A. D., Timmons, J., Greenspon, J., Eyvazzadeh, D., Murphy, E., Shea-Donahue, T., Cirimotich, S., Mongodin, E., Zhao, A., et al. (2013) · Gut Microbes · doi:10.4161/gmic.24706 · Cited by 54
Diagnosis, treatment and prevention of spontaneous bacterial peritonitis
Fernández, J., Bauer, T., Navasa, M., & Rodés, J. (2000) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2000.0142 · Cited by 54
Portal hypertension and variceal bleeding in patients with liver cancer: Evidence gaps for prevention and management
Allaire, M., & Thabut, D. (2023) · Hepatology · doi:10.1097/hep.0000000000000291 · Cited by 53
Bacterial DNA in the diagnosis of spontaneous bacterial peritonitis
Soriano, G., Esparcia, Ó., Montemayor, M., Guarner, C., Pericas, R., Torras, X., Calvo, N., Román, E. M., Navarro, F., Guarner, C., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04506.x · Cited by 53
VSL #3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride‐induced cirrhosis
Sánchez, E., Nieto, J. C., Boullosa, A., Vidal, S., Sancho, F. J., Rossi, G., Sancho‐Bru, P., Oms, R., Mirelis, B., Juárez, C., et al. (2014) · Liver International · doi:10.1111/liv.12566 · Cited by 52
Dysbiosis of the gut microbiome is associated with CKD5 and correlated with clinical indices of the disease: a case–controlled study
Li, Y., Su, X., Zhang, L., Liu, Y., Shi, M., Lv, C., Gao, Y., Xu, D., & Wang, Z. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1969-1 · Cited by 51
Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial
Kumar, M., Kainth, S., Choudhury, A. K., Maiwall, R., Mitra, L. G., Saluja, V., Agarwal, P., Shasthry, S. M., Jindal, A., Bhardwaj, A., et al. (2019) · Hepatology International · doi:10.1007/s12072-019-09986-9 · Cited by 52
Probiotics and Liver Disease
Sheth, A. A., & García–Tsao, G. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318169c44e · Cited by 50
Metabolic, antioxidant, nutraceutical, probiotic, and herbal therapies relating to the management of hepatobiliary disorders
Sharon A Center (2004) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2003.09.015 · Cited by 54
Intestinal permeability in a patient with liver cirrhosis
Aguirre-Valádez, J., Rivera-Espinosa, L., Méndez-Guerrero, O., Chávez-Pacheco, J. L., Juárez, I. G., & Torre, A. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s115902 · Cited by 52
Current and future pharmacological therapies for managing cirrhosis and its complications
Koeckerling, D., Nathwani, R., Forlano, R., Manousou, P., Mullish, B. H., & Dhar, A. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i8.888 · Cited by 49
Bacterial translocation: cause or consequence of decompensation in cirrhosis?
García–Tsao, G. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00006-4 · Cited by 49
No evidence for caspase-dependent apoptosis in acetaminophen hepatotoxicity
Jaeschke, H., Williams, C. D., & Farhood, A. I. (2010) · Hepatology · doi:10.1002/hep.23940 · Cited by 49
Multifactorial gut barrier failure in cirrhosis and bacterial translocation: working out the role of probiotics and antioxidants
Albillos, A., & de la Hera, A. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00265-9 · Cited by 48
Self-citation
Frequency and Severity of Cirrhotic Cardiomyopathy and Its Possible Relationship with Bacterial Endotoxemia
Karagiannakis, D. S., Vlachogiannakos, J., Anastasiadis, G., Vafiadis-Zouboulis, I., & Ladas, S. D. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2693-y · Cited by 46
Intestinal mucosal alterations in rats with carbon tetrachloride‐induced cirrhosis
Natarajan, S. K., Ramamoorthy, P., Thomas, S., Basivireddy, J., Kang, G., Ramachandran, A., Pulimood, A. B., & Balasubramanian, K. A. (2006) · Hepatology · doi:10.1002/hep.21097 · Cited by 46
Critical Role of the Liver in the Induction of Systemic Inflammation in Rats With Preascitic Cirrhosis
Cantera, M., Mun˜oz, L., Borrero, M., Díaz, D., Francés, R., Monserrat, J., Lario, M., Lledó, L., Such, J. M., Álvarez‐Mon, M., et al. (2010) · Hepatology · doi:10.1002/hep.23961 · Cited by 45
Self-citation
Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study
Abdel‐Razik, A., Mousa, N., Elhelaly, R. M., Elzehery, R. R., Hasan, A. S., Abdelsalam, M., Seif, A. S., Tawfik, A. M., El‐Wakeel, N., & Eldars, W. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00096 · Cited by 44

Authors: Pérez-Paramo, M., Muñoz, J., Albillos, A., Freile, I., Portero, F., Santos, M., & Ortiz-Berrocal, J.
ORCID: Muñoz, Javier
Santos, Martín
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2000-01
Volume: 31
Issue: 1
Pages: 43-48
ISSN: 0270-9139 (ISSN-L)
DOI: 10.1002/hep.510310109
OpenAlex: W2003357282
Cited by: 271
References: 25
Citations by year: 2026: 8 · 2025: 5 · 2024: 12 · 2023: 7 · 2022: 11 · 2021: 5 · 2020: 11 · 2019: 16 · 2018: 13 · 2017: 11 · 2016: 19 · 2015: 13 · 2014: 12 · 2013: 11 · 2012: 16
FWCI: 5.36
Type: journal article
Language: en
Open access: closed
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 5722 d)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Funders: Fondo de Investigaciones Sanitarias (99/0356)
Universidad de Alcalá (E001/98 y E002/99)
Programa Nacional de Salud from the Comisión Interministerial de Ciencia y Tecnología
Topics: Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: propranolol, bacterial translocation, liver cirrhosis, ascites, beta-blockers, intestinal bacterial overgrowth, intestinal transit, intestinal permeability, portal hypertension, spontaneous bacterial peritonitis, mesenteric lymph nodes
MeSH terms: Animals, Bacteria, Carbon Tetrachloride, Intestinal Absorption, Intestines, Liver Cirrhosis, Experimental, Lymph Nodes, Male, Mesentery, Propranolol, Technetium Tc 99m Pentetate, Rats, Sprague-Dawley, Bacterial Translocation, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks